Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
20/12/2024 13:10
Dec 20 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS ANNOUNCES TRANSITION FROM NASDAQ TO
OTC
MARKETS
* ALTAMIRA THERAPEUTICS LTD: NO REVERSE STOCK SPLIT PLANNED
* ALTAMIRA THERAPEUTICS LTD: TRADING TO CONTINUE UNDER
TICKER
SYMBOL "CYTOF"
Source text: ID:nGNEcdV1Qz
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering